Callan Family Office’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.82M Sell
20,031
-7,312
-27% -$1.33M 0.07% 238
2026
Q1
$5.18M Buy
27,343
+1,312
+5% +$279K 0.12% 188
2025
Q4
$5.96M Buy
26,031
+7,111
+38% +$1.56M 0.13% 169
2025
Q3
$3.75M Buy
18,920
+21
+0.1% +$4.18K 0.12% 180
2025
Q2
$3.73M Buy
18,899
+9,583
+103% +$1.86M 0.12% 188
2025
Q1
$1.91M Sell
9,316
-1,831
-16% -$400K 0.14% 131
2024
Q4
$2.56M Buy
11,147
+9,324
+511% +$2.29M 0.16% 121
2024
Q3
$507K Buy
1,823
+218
+14% +$57.7K 0.09% 102
2024
Q2
$401K Buy
1,605
+218
+16% +$55.1K 0.08% 104
2024
Q1
$346K Buy
+1,387
New +$338K 0.08% 71

Other funds holding DHR

Callan Family Office's DHR Position: Q2 2026 in Review

Callan Family Office reduced its Danaher (DHR) stake by 27% in Q2 2026, selling an estimated $1.33M and leaving 20,031 shares worth $3.82M. The position accounts for 0.07% of the portfolio, ranked #238.

Callan Family Office first reported a position in DHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.96M in Q4 2025. 2,094 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Callan Family Office held 20,031 shares of Danaher worth $3.82M as of Q2 2026.
  • Callan Family Office sold 7,312 Danaher shares in Q2 2026, an estimated $1.33M.
  • Danaher made up 0.07% of Callan Family Office's portfolio in Q2 2026, its #238 holding.
  • Callan Family Office first reported a position in Danaher in Q1 2024 and has held it in 10 quarters since.
  • Callan Family Office's Danaher position peaked at $5.96M in Q4 2025.
  • 2,094 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.